PHARMA MIX 1 — Pharmacom Labs

Part of the “Mixes Special Line” of injectable steroid blends. 

It is marketed as a “stack” (cocktail) combining three active steroid esters to support bulking / mass gain phases. 

pharmacomlabs.com

Active Ingredients & Composition

Active Agent Ester Type Approx. Concentration

Testosterone Phenylpropionate Short / fast-acting ester ~ 50 mg/mL 

Testosterone Cypionate Longer-acting ester ~ 200 mg/mL 

Boldenone (Undecylenate) Medium / long-acting ester (Undeclared, but implied as the third component) 

* Many sources list a total concentration around 450 mg/mL for the mix. 

The product is available as 10 mL vials / ampoules in the “Mix” line. 

pharmacomlabs.com

Marketing Claims / Purported Benefits

The blend is described as a “convenient stack” combining three agents in one vial to simplify dosing. 

Suitable for bulking / mass gain phases — aiming to build high-quality mass while reducing the need to mix multiple separate compounds. 

Balanced potency vs side effects: marketed as having a decent balance such that users can gain muscle without excessive adverse effects. 

Claims of efficiency / economy: combining in one product is suggested to be more affordable (or convenient) than purchasing the separate components. 

Usage / Dosing (as marketed by sources)

The marketed concentration is often cited as 450 mg/mL (i.e. a 10 mL vial containing ~4,500 mg total). 

pharma-grade.ws

Some sellers suggest weekly dosages (or split injections) and/or cycle lengths typical of anabolic steroid use (6–10 weeks) — although precise official instructions are not clearly published. 

Because the blend includes both fast and slower esters, injection scheduling is often suggested to accommodate both immediate and sustained release. (Implied in product marketing of mixed esters) 

Risks, Side Effects & Warnings (as implied / typical for such blends)

While not always spelled out in marketing text, given the nature of the components, standard risks include:

Suppression of endogenous testosterone (necessitating post-cycle therapy)

Androgenic side effects: acne, hair loss (in predisposed individuals), oily skin, virilization (in women)

Cardiovascular issues: changes in lipid profiles (lower HDL, raise LDL), blood pressure elevation

Estrogenic / aromatization risk: components (testosterone) may convert to estrogen, requiring anti-estrogen (e.g. aromatase inhibitors) for mitigation

Injection site reactions, pain, inflammation

Hepatic, renal strain: though injectables are less hepatotoxic than many oral steroids, risk remains

Quality / authenticity concerns: the brand itself warns of counterfeit / fake products in its general communications